EUCTR2005-004740-31-DK进行中（未招募）不适用
Efficacy of B-cell depletion with rituximab on oral, ocular and general disease manifestations in patients with primary Sjögren disease
niversity of Copenhagen0 个研究点目标入组 34 人开始时间: 2005年11月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Female patients with primary Sjögrens disease
- •Age 18-60 year
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnancy and lactation
- •Systemic treatment with cytostatics
- •Previous rituximab treatment
- •Active infection that requires antibiotic treatment
研究者
相似试验
招募中
不适用
Influence of B cell depletion therapy (rituximab) on (risk factors of) comorbidity in rheumatoid arthritisrheumatoid arthritis100822061000381610023213NL-OMON31299Vrije Universiteit Medisch Centrum50
尚未招募
不适用
Study on the efficacy of rituximab in patients with polymyalgia rheumaticapolymyalgia rheumaticaNL-OMON27507one. This is an investigator initiated trial50
尚未招募
2 期
Comparing Use of B-cell depletion therapy to Immunoglobulin in Chronic inflammatory demyelinating polyneuropathy (CUBIC) clinical trial.Chronic inflammatory demyelinating polyneuropathy (CIDP).Inflammatory and Immune System - Autoimmune diseasesNeurological - Other neurological disordersACTRN12623001336673Western Sydney Local Health District35
已完成
2 期
Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromePrimary Sjögren's SyndromeHyposalivationFatigueXerostomiaKeratoconjunctivitis SiccaNCT00426543University of Copenhagen21
已完成
不适用
Effect of three B-cell inhibitors: rituximab, alemtuzumab and bortezomib on anti-A and/or anti-B titer kinetics.kidneytransplant1001884910038430NL-OMON39959eids Universitair Medisch Centrum24